πŸ“£ VC round data is live. Check it out!

New China Life Insurance Valuation Multiples

Discover revenue and EBITDA valuation multiples for New China Life Insurance and similar public comparables like Helvetia Baloise Holding, Centene, Sampo, Aviva and more.

New China Life Insurance Overview

About New China Life Insurance

New China Life Insurance is headquartered in Beijing and was established in 1996 by a combination of state-owned enterprises and private firms. It is currently the fourth-largest life insurer in China based on total assets. The company is partly owned by Huijin Investment, the government’s investment arm, which holds a 31% stake in New China Life. In 2011, the company was listed on both the Hong Kong and Shanghai stock exchanges.New China Life offers a wide range of life insurance products and services to both individual and institutional customers through its extensive distribution networks and diverse marketing channels. Additionally, it manages and invests insurance funds through its subsidiaries, including its Asset Management Company and Asset Management Company (Hong Kong).


Founded

1996

HQ

China

Employees

28.7K

Financials (LTM)

Revenue: $23B
EBITDA: $6B

EV

$24B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

New China Life Insurance Financials

New China Life Insurance reported last 12-month revenue of $23B and EBITDA of $6B.

In the same LTM period, New China Life Insurance generated $6B in EBITDA and $5B in net income.

Revenue (LTM)


New China Life Insurance P&L

In the most recent fiscal year, New China Life Insurance reported revenue of $23B and EBITDA of $7B.

New China Life Insurance is profitable as of last fiscal year, with EBITDA margin of 33% and net margin of 23%.

See analyst estimates for New China Life Insurance
LTMLast FY202320242025202620272028
Revenue$23B$23B$10B$19B$22B
EBITDA$6B$7Bβ€”β€”$7B
EBITDA Margin28%33%β€”β€”33%
EBIT Margin23%24%β€”β€”24%
Net Profit$5B$5B$1B$4B$5B
Net Margin22%23%12%20%24%

Financial data powered by Morningstar, Inc.

New China Life Insurance Stock Performance

New China Life Insurance has current market cap of $27B, and enterprise value of $24B.

Market Cap Evolution


New China Life Insurance's stock price is $8.51.

New China Life Insurance share price increased by 0.6% in the last 30 days, and by 35.1% in the last year.

New China Life Insurance has an EPS (earnings per share) of $1.70.

See more trading valuation data for New China Life Insurance
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$24B$27B0.5%0.6%-12.8%35.1%$1.70

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

New China Life Insurance Valuation Multiples

New China Life Insurance trades at 1.1x EV/Revenue multiple, and 3.8x EV/EBITDA.

See NTM and 2027E valuation multiples for New China Life Insurance

EV / Revenue (LTM)


New China Life Insurance Financial Valuation Multiples

As of May 8, 2026, New China Life Insurance has market cap of $27B and EV of $24B.

New China Life Insurance has a P/E ratio of 5.2x.

LTMLast FY202320242025202620272028
EV/Revenue1.1x1.1x2.4x1.3x1.1x
EV/EBITDA3.8x3.3xβ€”β€”3.3x
EV/EBIT4.5x4.5xβ€”β€”4.5x
P/E5.2x5.0x20.8x6.9x5.0x
EV/FCFβ€”1.5x1.9x1.7x1.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified New China Life Insurance Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

New China Life Insurance Margins & Growth Rates

New China Life Insurance grew revenue by 4% but EBITDA decreased by 39% in the last fiscal year.

In the most recent fiscal year, New China Life Insurance reported EBITDA margin of 33% and net margin of 23%.

See estimated margins and future growth rates for New China Life Insurance

New China Life Insurance Margins

Last FY202420252026202720282029
EBITDA Margin33%β€”33%19%
EBIT Margin24%β€”24%22%
Net Margin23%20%24%20%
FCF Margin70%74%72%β€”

New China Life Insurance Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%84%18%7%
EBITDA Growth(39%)β€”β€”(39%)
EBIT Growth(4%)β€”β€”(4%)
Net Profit Growth(11%)201%38%(11%)
FCF Growthβ€”6%15%β€”

Data powered by FactSet, Inc. and Morningstar, Inc.

New China Life Insurance Operational KPIs

New China Life Insurance's revenue per employee in the last FY averaged $0.8M.

New China Life Insurance's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

New China Life Insurance's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for New China Life Insurance
LTMLast FY202320242025202620272028
Rule of 4033%26%β€”β€”β€”
Bessemer Rule of X41%36%β€”β€”β€”
Revenue per Employeeβ€”$0.8Mβ€”β€”β€”
G&A Expenses to Revenue2%2%3%2%2%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

New China Life Insurance Competitors

New China Life Insurance competitors include Helvetia Baloise Holding, Centene, Sampo, Aviva, Cincinnati Financial, WR Berkley, Humana Inc., QBE Insurance, NN Group and Markel Group.

Most New China Life Insurance public comparables operate across Insurance Carriers.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Helvetia Baloise Holding2.0x2.0xβ€”β€”
Centene0.1x0.1x14.6x12.3x
Sampo2.4x2.7x10.2x11.6x
Aviva0.1x0.1xβ€”β€”
Cincinnati Financial1.9x2.4xβ€”β€”
WR Berkley1.7x2.0x8.6x8.5x
Humana Inc.0.3x0.3x9.3x10.4x
QBE Insurance1.3x1.4x10.3x10.2x

This data is available for Pro users. Sign up to see all New China Life Insurance competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About New China Life Insurance

When was New China Life Insurance founded?New China Life Insurance was founded in 1996.
Where is New China Life Insurance headquartered?New China Life Insurance is headquartered in China.
How many employees does New China Life Insurance have?As of today, New China Life Insurance has over 28K employees.
Is New China Life Insurance publicly listed?Yes, New China Life Insurance is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of New China Life Insurance?New China Life Insurance trades under 601336 ticker.
When did New China Life Insurance go public?New China Life Insurance went public in 2011.
Who are competitors of New China Life Insurance?New China Life Insurance main competitors include Helvetia Baloise Holding, Centene, Sampo, Aviva, Cincinnati Financial, WR Berkley, Humana Inc., QBE Insurance, NN Group, Markel Group.
What is the current market cap of New China Life Insurance?New China Life Insurance's current market cap is $27B.
What is the current revenue of New China Life Insurance?New China Life Insurance's last 12 months revenue is $23B.
What is the current revenue growth of New China Life Insurance?New China Life Insurance revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of New China Life Insurance?Current revenue multiple of New China Life Insurance is 1.1x.
Is New China Life Insurance profitable?Yes, New China Life Insurance is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of New China Life Insurance?New China Life Insurance's last 12 months EBITDA is $6B.
What is New China Life Insurance's EBITDA margin?New China Life Insurance's last 12 months EBITDA margin is 28%.
What is the current EV/EBITDA multiple of New China Life Insurance?Current EBITDA multiple of New China Life Insurance is 3.8x.
How many companies New China Life Insurance has acquired to date?New China Life Insurance hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies New China Life Insurance has invested to date?New China Life Insurance hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to New China Life Insurance

Lists including New China Life Insurance

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial